-
Malaria test adapted to predict treatment side-effects
While most patients who receive the drug of choice (artemisinin artesunate) against malaria recuperate, a small number (less than 5 per cent) develop a serious and often fatal anaemia called post-artesunate delayed haemolysis (PADH) within a month of treatment.
- Categories
- Health Care
-
As warming brings more malaria, Kenya moves treatment closer to home
With just a medical kit and a mobile phone, health volunteers diagnose villagers with malaria in their own homes.
- Categories
- Environment, Health Care
- Region
- Sub-Saharan Africa
-
Malaria costs African economy US$12bn annually
Malaria related health expenditures and lost productivity cost Africa's economy an estimated US$12billion every year, a study has concluded.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- global health, malaria
-
The Side Effect Of That New Malaria Drug? American Jobs
The researchers found that between 2007 and 2015, the U.S. government invested $14 billion in global health research and development. And that created 200,000 new American jobs and returned $33 billion to the U.S. economy.
- Categories
- Health Care
-
Google releases 20 million mosquitos in Fresno, California
The so-called Debug Project by Alphabet’s life-sciences unit has set itself a lofty goal: “To reduce the devastating global health impact that disease-carrying mosquitoes inflict on people around the world.”
- Categories
- Health Care
- Region
- North America
-
After Successful Bed Net Campaigns in Ghana, Creating A Thriving, Sustainable Commercial Market
he number of malaria cases on the continent has dropped, with 6.8 million lives saved since 2000. Sixty percent of that can be attributed to insecticide-treated bed nets. It’s the single most-effective tool against malaria.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
BASF unveils new mosquito net in battle against malaria
A new mosquito net made by German chemicals company BASF has been given an interim recommendation by the World Health Organization (WHO), containing a new class of insecticide that the company hopes will aid the fight against malaria.
- Categories
- Health Care
-
Large market share for non-quality-assured malaria medicines in Africa
A new study of malaria medicine quality in 8 sub-Saharan African countries has found a large and potentially growing market for non-quality-assured (QA) malaria treatments—medicines not pre-approved by global health organizations - as much as 20% of the private-sector market in Kenya, and 42% in the Democratic Republic of Congo (DRC).
- Categories
- Health Care
- Region
- Sub-Saharan Africa
Parent Organization
